Arena Pharmaceuticals Inc (NASDAQ:ARNA)

Data as of Oct 21
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovery, development and commercialization of drugs in the therapeutic areas such as cardiovascular, central nervous system, inflammatory and metabolic diseases. Its product pipeline includes Lorcaserin, APD811, APD334, APD371, GPR119 agonists, temanogrel and nelotanserin. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.

Contact Information

Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego California 92121
P:(858) 453-7200
Investor Relations:



Individual stakeholders4.63%
Mutual fund holders26.70%
Other institutional21.60%

Top Executives

Jack LiefChairman, President & Chief Executive Officer
Craig M. AudetSVP-Operations & Head-Global Regulatory Affairs
Robert E. HoffmanChief Financial Officer & Senior Vice President
Dominic P. BehanChief Scientific Officer, Executive Director & EVP
William R. ShanahanChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.